92 related articles for article (PubMed ID: 8387074)
21. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
Champelovier P; Boucard N; Levacher G; Simon A; Seigneurin D; Praloran V
Urol Res; 2002 Oct; 30(5):301-9. PubMed ID: 12389118
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.
Dinney CP; Bielenberg DR; Perrotte P; Reich R; Eve BY; Bucana CD; Fidler IJ
Cancer Res; 1998 Feb; 58(4):808-14. PubMed ID: 9485039
[TBL] [Abstract][Full Text] [Related]
23. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T
Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
25. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Inoue K; Perrotte P; Wood CG; Slaton JW; Sweeney P; Dinney CP
Clin Cancer Res; 2000 Nov; 6(11):4422-31. PubMed ID: 11106263
[TBL] [Abstract][Full Text] [Related]
27. Interaction of basic fibroblast growth factor (FGF-2) with nonresponsive HeLa cells.
Gannoun-Zaki L; Pieri I; Badet J; Barritault D
Exp Cell Res; 1994 Aug; 213(2):375-82. PubMed ID: 8050494
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer.
Chodak GW; Hospelhorn V; Judge SM; Mayforth R; Koeppen H; Sasse J
Cancer Res; 1988 Apr; 48(8):2083-8. PubMed ID: 3349479
[TBL] [Abstract][Full Text] [Related]
29. Mediation of virion penetration into vascular cells by association of basic fibroblast growth factor with herpes simplex virus type 1.
Baird A; Florkiewicz RZ; Maher PA; Kaner RJ; Hajjar DP
Nature; 1990 Nov; 348(6299):344-6. PubMed ID: 2174511
[TBL] [Abstract][Full Text] [Related]
30. Correlation of transformation from epithelial to mesenchymal-like morphology and endogenous bFGF levels in human nasopharyngeal carcinoma cells.
Chen JK; Shen LS; Chao HH
J Cell Physiol; 1994 Sep; 160(3):401-8. PubMed ID: 8077277
[TBL] [Abstract][Full Text] [Related]
31. Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Marzioni D; Lorenzi T; Mazzucchelli R; Capparuccia L; Morroni M; Fiorini R; Bracalenti C; Catalano A; David G; Castellucci M; Muzzonigro G; Montironi R
Int J Immunopathol Pharmacol; 2009; 22(3):627-38. PubMed ID: 19822079
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal-epithelial interactions between normal and transformed human bladder cells.
Pritchett TR; Wang JK; Jones PA
Cancer Res; 1989 May; 49(10):2750-4. PubMed ID: 2713858
[TBL] [Abstract][Full Text] [Related]
33. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
Tetzke TA; Caton MC; Maher PA; Parandoosh Z
Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the growth of a human nasopharyngeal carcinoma cell line by bFGF is mediated via FGFR-1.
Chen JK; Chao HH; Yang VC
FASEB J; 1995 Sep; 9(12):1211-9. PubMed ID: 7672514
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
Miller K; Wilder PJ; Rizzino A
Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
[TBL] [Abstract][Full Text] [Related]
36. Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells.
Presta M; Urbinati C; Dell'era P; Lauro GM; Sogos V; Balaci L; Ennas MG; Gremo F
Int J Dev Neurosci; 1995 Feb; 13(1):29-39. PubMed ID: 7793308
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of adipose tissue stromal cells on the apoptosis, growth and invasion of bladder urothelial carcinoma between the superficial and invasive types.
Kawasaki-Nanri M; Aoki S; Uchihashi K; Yamamoto M; Udo K; Nishijima-Matsunobu A; Kakihara N; Noguchi M; Uozumi J; Toda S
Int J Urol; 2016 Jun; 23(6):510-9. PubMed ID: 27020040
[TBL] [Abstract][Full Text] [Related]
38. Targets of fibroblast growth factor 1 (FGF-1) and FGF-2 signaling involved in the invasive and tumorigenic behavior of carcinoma cells.
Billottet C; Elkhatib N; Thiery JP; Jouanneau J
Mol Biol Cell; 2004 Oct; 15(10):4725-34. PubMed ID: 15282342
[TBL] [Abstract][Full Text] [Related]
39. Epithelial cell plasticity in development and tumor progression.
Thiery JP; Chopin D
Cancer Metastasis Rev; 1999; 18(1):31-42. PubMed ID: 10505544
[TBL] [Abstract][Full Text] [Related]
40. Messenger ribonucleic acids for fibroblast growth factors and their receptor in bladder and renal cell carcinoma cell lines.
Yoshimura K; Eto H; Miyake H; Hara I; Arakawa S; Kamidono S
Cancer Lett; 1996 May; 103(1):91-7. PubMed ID: 8616814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
